Usefulness of FibroScan for detection of early compensated @entity1575 in XXXX .

@entity1 @entity82 @entity409 @entity5906 @entity6194 @entity3929 @entity1575 @entity3619
BACKGROUND: It is difficult to differentiate early compensated @entity82 from @entity3619 solely by clinical features. The aim of this study was to assess the usefulness of @entity409 measurement (LSM) for detection of early compensated @entity1575 in @entity6194 ( @entity6194 ). METHODS: Ninety-one consecutive @entity6194 @entity1 who underwent liver biopsy (LB) and LSM were recruited. All @entity1 did not fulfill the clinical criteria for @entity82 . The cutoff of LSM for @entity82 was 10.3 kPa. RESULTS: All @entity1 were divided into either group A ( @entity82 ) or group B ( @entity6194 ) according to LB result. The median LSM values of groups A and B were 11.8 and 7.6 kPa, respectively (P < 0.001). The sensitivity, specificity, positive predictive value, and negative predictive value of LSM in predicting @entity82 were 0.59, 0.78, 0.68, and 0.72, respectively. The area under the receiver operating characteristics curve (AUROC) of LSM was 0.803, whereas the AUROCs of @entity5906 to @entity3929 aminotransferase ratio (AAR) and @entity5906 aminotransferase to platelet ratio index (APRI) were 0.488 and 0.723, respectively. CONCLUSIONS: LSM showed an acceptable diagnostic accuracy for detecting early compensated @entity82 in @entity6194 .
